Skip to content
Breaking News

Breaking News

  • Home
  • World
  • Business
  • Health
  • Entertainment
  • Life Style
  • Sports
  • Toggle search form

Wegovy-maker Novo Nordisk raises outlook as sales of its weight-loss drug soar

Posted on August 10, 2023 By Admin No Comments on Wegovy-maker Novo Nordisk raises outlook as sales of its weight-loss drug soar


A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. 

Jim Vondruska | Reuters

Novo Nordisk, which makes the weight-loss drug Wegovy, raised its outlook for 2023 Thursday, as it reported soaring sales.

The Danish pharmaceutical company reported a 30% increase in sales, at constant exchange rates, for the first half of this year to 107.7 million Danish kroner ($15.9 million). Net profit increased 43%, coming in at 39.2 million kroner.

The company’s diabetes and obesity division performed particularly well, bolstered by interest in its blockbuster injection Wegovy.

“The [sales] growth is driven by increasing demand for our GLP-1-based diabetes and obesity treatments, and we are serving more patients than ever before,” Lars Fruergaard Jørgensen, president and CEO, said in a statement. “The performance in the first six months has enabled us to raise the outlook for the full year.”

For 2023, the company now anticipates sales growth of 27%-33% and operating profit growth of 31%-37%, at constant exchange rates.

Last week, late-stage trial data showed that Wegovy reduced the risk of major cardiovascular events such as heart attacks or strokes by 20%, compared with a placebo, sending shares higher.

The results of the closely watched “SELECT” trial, which exceeded expectations, were seen as a major boost for the company’s hopes of moving beyond Wegovy’s image as a “vanity drug.”

The active ingredient in Wegovy is semaglutide, an FDA-approved drug that works by imitating a naturally-occurring gut hormone that helps to regulate appetite.

Shares are up almost 1% in pre-market trading.

— Sam Meredith contributed to this report.



Source link

Health Tags:business news, Earnings, Health care industry, Novo Nordisk A/S

Post navigation

Previous Post: Amazon in talks to become anchor investor in Arm ahead of IPO  – Reuters News Agency
Next Post: Wells Fargo Reflect Card Review

More Related Articles

Is chocolate bad for your skin? – SUCH TV Health
Space Anemia: A Serious Health Risk For NASA Astronaut Sunita Williams Health
Study examines connection of language with likeliness of stroke in humans Health
‘I’m struggling to discipline my toddler in public settings. Please help!’ Health
PCOS Weight Loss Journey: Woman Loses 38 Kg And Shares 10 Common Mistakes To Avoid For Faster Results Health
With a bit of grit and grace | The Express Tribune Health

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Ryanair to increase oversized bag bonus
  • Man receives world’s first pig lung transplant in groundbreaking medical procedure
  • India cricket ends $43.6m sponsorship after online gambling ban: report
  • Morgan Wallen joins artists pushing back on Grammys
  • Zara Noor Abbas, Zahid Ahmed bring grace and grit to Dil Dhoondta Hai Phir Wohi | The Express Tribune

Categories

  • Business
  • Entertainment
  • Health
  • Life Style
  • Sports
  • World

Copyright © 2025 Breaking News.

Powered by PressBook Blog WordPress theme